MTRAX
Price
$20.49
Change
+$0.05 (+0.24%)
Updated
Jan 17 closing price
Net Assets
1.03B
RIRBX
Price
$70.01
Change
+$0.35 (+0.50%)
Updated
Jan 17 closing price
Net Assets
106.93B
Ad is loading...

MTRAX vs RIRBX

Header iconMTRAX vs RIRBX Comparison
Open Charts MTRAX vs RIRBXBanner chart's image
NYLI Income Builder
Price$20.49
Change+$0.05 (+0.24%)
VolumeN/A
Net Assets1.03B
American Funds Capital Income Bldr R2
Price$70.01
Change+$0.35 (+0.50%)
VolumeN/A
Net Assets106.93B
MTRAX vs RIRBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MTRAX vs. RIRBX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTRAX is a Hold and RIRBX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RIRBX has more cash in the bank: 107B vs. MTRAX (1.03B). MTRAX pays higher dividends than RIRBX: MTRAX (2.86) vs RIRBX (2.55). MTRAX was incepted earlier than RIRBX: MTRAX (30 years) vs RIRBX (23 years). RIRBX is a more actively managed with annual turnover of: 106.00 vs. MTRAX (56.00). RIRBX has a lower initial minimum investment than MTRAX: RIRBX (250) vs MTRAX (15000). MTRAX annual gain was more profitable for investors over the last year : 13.73 vs. RIRBX (9.89). RIRBX return over 5 years is better than : 19.51 vs. MTRAX (16.10).
MTRAXRIRBXMTRAX / RIRBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years23 years-
Gain YTD1.4861.405106%
Front LoadN/AN/A-
Min. Initial Investment150002506,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.03B107B1%
Annual Yield % from dividends2.862.55112%
Returns for 1 year13.739.89139%
Returns for 3 years8.545.65151%
Returns for 5 years16.1019.5183%
Returns for 10 years28.4830.0995%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTCT43.840.76
+1.76%
PTC Therapeutics
CBAN15.840.22
+1.41%
Colony Bankcorp Inc
ABCL2.970.03
+1.02%
AbCellera Biologics
PAVM0.650.01
+0.81%
PAVmed
EXPE187.28-1.39
-0.74%
Expedia Group